Global Female Infertility Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Female Infertility Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Female Infertility Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Female Infertility Drugs by Country/Region, 2017, 2022 & 2028

2.2 Female Infertility Drugs Segment by Type

2.2.1 Parenteral

2.2.2 Oral

2.2.3 Others

2.3 Female Infertility Drugs Sales by Type

2.3.1 Global Female Infertility Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Female Infertility Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Female Infertility Drugs Sale Price by Type (2017-2022)

2.4 Female Infertility Drugs Segment by Application

2.4.1 Fertility Clinics

2.4.2 Hospitals

2.4.3 Cryobanks

2.5 Female Infertility Drugs Sales by Application

2.5.1 Global Female Infertility Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Female Infertility Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Female Infertility Drugs Sale Price by Application (2017-2022)

3 Global Female Infertility Drugs by Company

3.1 Global Female Infertility Drugs Breakdown Data by Company

3.1.1 Global Female Infertility Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Female Infertility Drugs Sales Market Share by Company (2020-2022)

3.2 Global Female Infertility Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Female Infertility Drugs Revenue by Company (2020-2022)

3.2.2 Global Female Infertility Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Female Infertility Drugs Sale Price by Company

3.4 Key Manufacturers Female Infertility Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Female Infertility Drugs Product Location Distribution

3.4.2 Players Female Infertility Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Female Infertility Drugs by Geographic Region

4.1 World Historic Female Infertility Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Female Infertility Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Female Infertility Drugs Annual Revenue by Geographic Region

4.2 World Historic Female Infertility Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Female Infertility Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Female Infertility Drugs Annual Revenue by Country/Region

4.3 Americas Female Infertility Drugs Sales Growth

4.4 APAC Female Infertility Drugs Sales Growth

4.5 Europe Female Infertility Drugs Sales Growth

4.6 Middle East & Africa Female Infertility Drugs Sales Growth

5 Americas

5.1 Americas Female Infertility Drugs Sales by Country

5.1.1 Americas Female Infertility Drugs Sales by Country (2017-2022)

5.1.2 Americas Female Infertility Drugs Revenue by Country (2017-2022)

5.2 Americas Female Infertility Drugs Sales by Type

5.3 Americas Female Infertility Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Female Infertility Drugs Sales by Region

6.1.1 APAC Female Infertility Drugs Sales by Region (2017-2022)

6.1.2 APAC Female Infertility Drugs Revenue by Region (2017-2022)

6.2 APAC Female Infertility Drugs Sales by Type

6.3 APAC Female Infertility Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Female Infertility Drugs by Country

7.1.1 Europe Female Infertility Drugs Sales by Country (2017-2022)

7.1.2 Europe Female Infertility Drugs Revenue by Country (2017-2022)

7.2 Europe Female Infertility Drugs Sales by Type

7.3 Europe Female Infertility Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Female Infertility Drugs by Country

8.1.1 Middle East & Africa Female Infertility Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Female Infertility Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Female Infertility Drugs Sales by Type

8.3 Middle East & Africa Female Infertility Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Female Infertility Drugs

10.3 Manufacturing Process Analysis of Female Infertility Drugs

10.4 Industry Chain Structure of Female Infertility Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Female Infertility Drugs Distributors

11.3 Female Infertility Drugs Customer

12 World Forecast Review for Female Infertility Drugs by Geographic Region

12.1 Global Female Infertility Drugs Market Size Forecast by Region

12.1.1 Global Female Infertility Drugs Forecast by Region (2023-2028)

12.1.2 Global Female Infertility Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Female Infertility Drugs Forecast by Type

12.7 Global Female Infertility Drugs Forecast by Application

13 Key Players Analysis

13.1 Allergan Plc

13.1.1 Allergan Plc Company Information

13.1.2 Allergan Plc Female Infertility Drugs Product Offered

13.1.3 Allergan Plc Female Infertility Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Plc Main Business Overview

13.1.5 Allergan Plc Latest Developments

13.2 Ferring BV

13.2.1 Ferring BV Company Information

13.2.2 Ferring BV Female Infertility Drugs Product Offered

13.2.3 Ferring BV Female Infertility Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ferring BV Main Business Overview

13.2.5 Ferring BV Latest Developments

13.3 Merck KGaA

13.3.1 Merck KGaA Company Information

13.3.2 Merck KGaA Female Infertility Drugs Product Offered

13.3.3 Merck KGaA Female Infertility Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck KGaA Main Business Overview

13.3.5 Merck KGaA Latest Developments

13.4 Novartis AG

13.4.1 Novartis AG Company Information

13.4.2 Novartis AG Female Infertility Drugs Product Offered

13.4.3 Novartis AG Female Infertility Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis AG Main Business Overview

13.4.5 Novartis AG Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Female Infertility Drugs Product Offered

13.5.3 Sanofi Female Infertility Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

14 Research Findings and Conclusion

Table 1. Female Infertility Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Female Infertility Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Parenteral

Table 4. Major Players of Oral

Table 5. Major Players of Others

Table 6. Global Female Infertility Drugs Sales by Type (2017-2022) & (K Units)

Table 7. Global Female Infertility Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Female Infertility Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Female Infertility Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Female Infertility Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Female Infertility Drugs Sales by Application (2017-2022) & (K Units)

Table 12. Global Female Infertility Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Female Infertility Drugs Revenue by Application (2017-2022)

Table 14. Global Female Infertility Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Female Infertility Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Female Infertility Drugs Sales by Company (2020-2022) & (K Units)

Table 17. Global Female Infertility Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Female Infertility Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Female Infertility Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Female Infertility Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Female Infertility Drugs Producing Area Distribution and Sales Area

Table 22. Players Female Infertility Drugs Products Offered

Table 23. Female Infertility Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Female Infertility Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Female Infertility Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Female Infertility Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Female Infertility Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Female Infertility Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Female Infertility Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Female Infertility Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Female Infertility Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Female Infertility Drugs Sales by Country (2017-2022) & (K Units)

Table 35. Americas Female Infertility Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Female Infertility Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Female Infertility Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Female Infertility Drugs Sales by Type (2017-2022) & (K Units)

Table 39. Americas Female Infertility Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Female Infertility Drugs Sales by Application (2017-2022) & (K Units)

Table 41. Americas Female Infertility Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Female Infertility Drugs Sales by Region (2017-2022) & (K Units)

Table 43. APAC Female Infertility Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Female Infertility Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Female Infertility Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Female Infertility Drugs Sales by Type (2017-2022) & (K Units)

Table 47. APAC Female Infertility Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Female Infertility Drugs Sales by Application (2017-2022) & (K Units)

Table 49. APAC Female Infertility Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Female Infertility Drugs Sales by Country (2017-2022) & (K Units)

Table 51. Europe Female Infertility Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Female Infertility Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Female Infertility Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Female Infertility Drugs Sales by Type (2017-2022) & (K Units)

Table 55. Europe Female Infertility Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Female Infertility Drugs Sales by Application (2017-2022) & (K Units)

Table 57. Europe Female Infertility Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Female Infertility Drugs Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Female Infertility Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Female Infertility Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Female Infertility Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Female Infertility Drugs Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Female Infertility Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Female Infertility Drugs Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Female Infertility Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Female Infertility Drugs

Table 67. Key Market Challenges & Risks of Female Infertility Drugs

Table 68. Key Industry Trends of Female Infertility Drugs

Table 69. Female Infertility Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Female Infertility Drugs Distributors List

Table 72. Female Infertility Drugs Customer List

Table 73. Global Female Infertility Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Female Infertility Drugs Sales Market Forecast by Region

Table 75. Global Female Infertility Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Female Infertility Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Female Infertility Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Female Infertility Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Female Infertility Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Female Infertility Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Female Infertility Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Female Infertility Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Female Infertility Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Female Infertility Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Female Infertility Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Female Infertility Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Female Infertility Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Female Infertility Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Female Infertility Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Female Infertility Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Female Infertility Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Female Infertility Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan Plc Basic Information, Female Infertility Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan Plc Female Infertility Drugs Product Offered

Table 95. Allergan Plc Female Infertility Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Allergan Plc Main Business

Table 97. Allergan Plc Latest Developments

Table 98. Ferring BV Basic Information, Female Infertility Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Ferring BV Female Infertility Drugs Product Offered

Table 100. Ferring BV Female Infertility Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Ferring BV Main Business

Table 102. Ferring BV Latest Developments

Table 103. Merck KGaA Basic Information, Female Infertility Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck KGaA Female Infertility Drugs Product Offered

Table 105. Merck KGaA Female Infertility Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Merck KGaA Main Business

Table 107. Merck KGaA Latest Developments

Table 108. Novartis AG Basic Information, Female Infertility Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Novartis AG Female Infertility Drugs Product Offered

Table 110. Novartis AG Female Infertility Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Novartis AG Main Business

Table 112. Novartis AG Latest Developments

Table 113. Sanofi Basic Information, Female Infertility Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Sanofi Female Infertility Drugs Product Offered

Table 115. Sanofi Female Infertility Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Sanofi Main Business

Table 117. Sanofi Latest Developments

List of Figures

Figure 1. Picture of Female Infertility Drugs

Figure 2. Female Infertility Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Female Infertility Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Female Infertility Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Female Infertility Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Parenteral

Figure 10. Product Picture of Oral

Figure 11. Product Picture of Others

Figure 12. Global Female Infertility Drugs Sales Market Share by Type in 2021

Figure 13. Global Female Infertility Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Female Infertility Drugs Consumed in Fertility Clinics

Figure 15. Global Female Infertility Drugs Market: Fertility Clinics (2017-2022) & (K Units)

Figure 16. Female Infertility Drugs Consumed in Hospitals

Figure 17. Global Female Infertility Drugs Market: Hospitals (2017-2022) & (K Units)

Figure 18. Female Infertility Drugs Consumed in Cryobanks

Figure 19. Global Female Infertility Drugs Market: Cryobanks (2017-2022) & (K Units)

Figure 20. Global Female Infertility Drugs Sales Market Share by Application (2017-2022)

Figure 21. Global Female Infertility Drugs Revenue Market Share by Application in 2021

Figure 22. Female Infertility Drugs Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Female Infertility Drugs Revenue Market Share by Company in 2021

Figure 24. Global Female Infertility Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Female Infertility Drugs Revenue Market Share by Geographic Region in 2021

Figure 26. Global Female Infertility Drugs Sales Market Share by Region (2017-2022)

Figure 27. Global Female Infertility Drugs Revenue Market Share by Country/Region in 2021

Figure 28. Americas Female Infertility Drugs Sales 2017-2022 (K Units)

Figure 29. Americas Female Infertility Drugs Revenue 2017-2022 ($ Millions)

Figure 30. APAC Female Infertility Drugs Sales 2017-2022 (K Units)

Figure 31. APAC Female Infertility Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Europe Female Infertility Drugs Sales 2017-2022 (K Units)

Figure 33. Europe Female Infertility Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Female Infertility Drugs Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Female Infertility Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Americas Female Infertility Drugs Sales Market Share by Country in 2021

Figure 37. Americas Female Infertility Drugs Revenue Market Share by Country in 2021

Figure 38. United States Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Female Infertility Drugs Sales Market Share by Region in 2021

Figure 43. APAC Female Infertility Drugs Revenue Market Share by Regions in 2021

Figure 44. China Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Female Infertility Drugs Sales Market Share by Country in 2021

Figure 51. Europe Female Infertility Drugs Revenue Market Share by Country in 2021

Figure 52. Germany Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Female Infertility Drugs Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Female Infertility Drugs Revenue Market Share by Country in 2021

Figure 59. Egypt Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Female Infertility Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Female Infertility Drugs in 2021

Figure 65. Manufacturing Process Analysis of Female Infertility Drugs

Figure 66. Industry Chain Structure of Female Infertility Drugs

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles